Summary
Bayer AG (Bayer) is a German multinational pharmaceutical and biotechnology company that discovers, develops, manufactures, and commercializes a wide range of human health and agriculture products. The company manufactures and markets consumer health, pet care, cosmetics & toiletries (C&T), household, and baby care products. Most of the company’s sales come from the consumer health industry (96.4%). Bayer operates its business across all regions worldwide. Its major business is concentrated in North America, which accounted for 43.9% of value sales in 2022.Scope
- North America is the leading revenue generating region for Bayer
- The consumer health industry is set to grow the fastest in North America
- West Europe and Asia to present growth prospects for Bayer through 2027
- Sentiment score sees a declining trend after November 2022
Reasons to Buy
- Understand the challenges and opportunities for a specific company in order to tap into what is really impacting the industry.
- Gain a broader appreciation of the fast-moving consumer goods industry by gaining insights from both within and outside of your sector.
- Access valuable strategic take-outs to help direct future decision-making and inform new product development.
Table of Contents
- Company snapshot
- Company overview
- Sales by region and industry
- Sector forecast overview by region
- Sales performance outlook
- News and deals
- Recruitment trends
- Social media trends
- Key themes
- Appendix
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Bayer AG